Serpin Family A Member 1 Is Prognostic and Involved in Immunological Regulation in Human Cancers.

Abstract

Serpin family A member 1 (SERPINA1) encodes a protease inhibitor participating in many human diseases, but its value in immunoregulation and prognosis of human cancers remains unclear. In this study, through comprehensive analysis of data from The Cancer Genome Atlas (TCGA) datasets, we found that SERPINA1 was dysregulated in many cancers compared with normal tissues. SERPINA1 expression was significantly associated with prognosis, immune subtype, molecular subtype, immune checkpoint (ICP) genes, tumor mutational burden (TMB), microsatellite instability (MSI), and the estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) score. There was a strong connection between SERPINA1 expression and tumor-infiltrating lymphocytes, and SERPINA1 showed significant relation to gene markers of immune cells in digestive tumors. Fluorescence-based multiplex immunohistochemistry confirmed that SERPINA1 protein expression was related to clinicopathologic features and immune infiltrates in hepatic cancer. This study suggests that SERPINA can potentially serve as a novel biomarker for cancer prognosis and immunotherapy.

• Authors: Xingwang Kuai, Jiaying Lv, Junyu Zhang, Manyu Xu, Juling Ji
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 14 (Jul 17 2023) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 37511325 (Publication Type: Journal Article)

Chemical References

• Antiviral Agents
• Protease Inhibitors
• SERPINA1 protein, human

Topics

• Humans
• Antiviral Agents
• Enzyme Therapy
• Liver Neoplasms (genetics)
• Prognosis
• Protease Inhibitors